Skip to main content

Pressure Ulcers

0
Pipeline Programs
10
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Precision BioSciences
2 programs
DermaTherapy® Linen and underpads.N/A1 trial
DermaTherapy® Linen and underpads.N/A1 trial
Active Trials
NCT01355666Unknown75Est. Jun 2011
NCT01403272Completed75Est. Jun 2011
Leaf Healthcare
Leaf HealthcareCA - Pleasanton
1 program
DynaSense sensorN/A
Centauri Therapeutics
1 program
DynaSense sensorN/A1 trial
Active Trials
NCT02005692Completed70Est. Feb 2014
Kerecis
KerecisIceland - Isafjordur
1 program
Marigen Wound DressingN/A1 trial
Active Trials
NCT01348581Completed37Est. Jan 2013
Baxter
BaxterCosta Rica - Cartago
1 program
P500 MattressN/A
Baxter International
1 program
P500 MattressN/A1 trial
Active Trials
NCT00771238Completed52Est. Jan 2010
Organogenesis
OrganogenesisCANTON, MA
1 program
PuraPly™ Antimicrobial Wound MatrixN/A1 trial
Active Trials
NCT03070925Completed43Est. May 2017
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Musical promptPHASE_2_31 trial
Active Trials
NCT01008254Completed2,000Est. May 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonMusical prompt
OrganogenesisPuraPly™ Antimicrobial Wound Matrix
Centauri TherapeuticsDynaSense sensor
KerecisMarigen Wound Dressing
Precision BioSciencesDermaTherapy® Linen and underpads.
Precision BioSciencesDermaTherapy® Linen and underpads.
Baxter InternationalP500 Mattress

Clinical Trials (7)

Total enrollment: 2,352 patients across 7 trials

NCT01008254Johnson & JohnsonMusical prompt

Interdisciplinary Mobility Approach To Reduction Of Facility-Acquired Pressure Ulcers

Start: Sep 2009Est. completion: May 20112,000 patients
Phase 2/3Completed
NCT03070925OrganogenesisPuraPly™ Antimicrobial Wound Matrix

Prospective PuraPly™ AM Case Series Study

Start: Nov 2016Est. completion: May 201743 patients
N/ACompleted
NCT02005692Centauri TherapeuticsDynaSense sensor

A Pilot Study to Assess the DynaSense System

Start: Dec 2013Est. completion: Feb 201470 patients
N/ACompleted
NCT01348581KerecisMarigen Wound Dressing

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Start: Nov 2010Est. completion: Jan 201337 patients
N/ACompleted
NCT01403272Precision BioSciencesDermaTherapy® Linen and underpads.

Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting

Start: Sep 2010Est. completion: Jun 201175 patients
N/ACompleted
NCT01355666Precision BioSciencesDermaTherapy® Linen and underpads.

Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting

Start: Sep 2010Est. completion: Jun 201175 patients
N/AUnknown
NCT00771238Baxter InternationalP500 Mattress

Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds

Start: Nov 2008Est. completion: Jan 201052 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

10 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.